Back

Evolution of FXI(a) as a target for antithrombotic therapy

27 August 2023 (10:30 - 10:40)
Organised by: Logo
Congress Presentation Part of: How can targeting FXI(a) advance antithrombotic therapy for stroke prevention? Stroke in Atrial Fibrillation Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor M. Sharma (Hamilton, CA)
Presentation thumbnail
Epidemiology of stroke and disease burden
Professor M. Blomstrom-Lundqvist (Orebro, SE)
Presentation thumbnail
Uncovering the unmet need for patients: - with atrial fibrillation at risk of stroke - acute non-cardioembolic ischemic stroke or high-risk TIA
Professor M. Blomstrom-Lundqvist (Orebro, SE) Professor M. Sharma (Hamilton, CA)
Presentation thumbnail
Outlining the clinical evidence landscape for FXI(a) inhibition: - stroke and bleeding prevention for patients with AF at risk of stroke - secondary stroke prevention in acute non-cardioembolic ischemic stroke or high-risk TIA
Professor J. De Groot (Amsterdam, NL) Professor M. Sharma (Hamilton, CA)
Presentation thumbnail
Q&A and closing remarks

Access the full session

Session thumbnail
How can targeting FXI(a) advance antithrombotic therapy for stroke prevention?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 10:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources